Product
Capecitabine + Placebo combined with Toripalimab
1 clinical trial
2 indications
Indication
Nasopharyngeal CarcinomaIndication
Maintenance TherapyClinical trial
The Efficacy and Safety of Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma:Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Clinical StudyStatus: Recruiting, Estimated PCD: 2026-04-28